3LI YC. Podocytes as target of vitamin D[J]. Curt Diabetes Rev, 2011, 7(1): 35-40.
4XIAO H,SHI W,LIU S, et O1. 1,25-Dihydroxyvitamin D (3) prevents puromyein aminonucleoside-induced apoptosis of glome- rular podocytes by activating the phosphatidylinositol 3-kinase/ Akt-signaling pathway[J]. Am J Nephrol, 2009, 30(1): 34-43.
5XIAO HQ, SHI W, LIU SX, et d. Podoeyte injury is supp- ressed by 1,25-dihydroxyvitamin D via modulating of transfor- ming growth factor-betal/bone morphogenetic protein-7 signall- ing in puromycin aminonucleoside nephropathy rats[J]. Clin Exp Pharmacol Physiol, 2009, 36(7): 682-689.
6BLASI F, CARMELIET P. uPAR: a versatile signaling orches- trator[J]. Nat Rev Mol Cell Biol, 2002, 3(12): 932-943.
7WEI C, MOLLER CC, ALTINTAS MM, et al. Modification of kidney barrier function by the urokinase receptor[J]. Nat Med, 2008, 14(1): 55-63.
8WEI C, el HINDI S, LI J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis [J]. Nat Med, 2011, 17(8): 952-960.
9SHANKLAND SJ, PIPPIN JW, REISER J, et O1. Podocytes in culture: past, present, and future[J]. Kidney Int, 2007, 72(1): 26-36.
10ASANUMA K, YANAGIDA-ASANUMA E, FAUL C, et ol. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling [J]. Nat Cell Biol, 2006, 8(5): 485-491.
